Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Current Leases: 2022-2024

Historic Current Leases for Sunshine Biopharma (SBFM) over the last 3 years, with Dec 2024 value amounting to $207,756.

  • Sunshine Biopharma's Current Leases rose 87.57% to $218,053 in Q3 2025 from the same period last year, while for Sep 2025 it was $218,053, marking a year-over-year increase of 87.57%. This contributed to the annual value of $207,756 for FY2024, which is 75.07% up from last year.
  • Sunshine Biopharma's Current Leases amounted to $207,756 in FY2024, which was up 75.07% from $118,670 recorded in FY2023.
  • In the past 5 years, Sunshine Biopharma's Current Leases ranged from a high of $207,756 in FY2024 and a low of $118,670 during FY2023.
  • In the last 3 years, Sunshine Biopharma's Current Leases had a median value of $123,026 in 2022 and averaged $149,817.
  • As far as peak fluctuations go, Sunshine Biopharma's Current Leases decreased by 3.54% in 2023, and later soared by 75.07% in 2024.
  • Over the past 3 years, Sunshine Biopharma's Current Leases (Yearly) stood at $123,026 in 2022, then dropped by 3.54% to $118,670 in 2023, then surged by 75.07% to $207,756 in 2024.